Form EFFECT RedHill Biopharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 |
| Accession Number: | 0001178913-25-003255 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Easton & Easton Earns 58 #1 Rankings from TopVerdict -- Including Back-to-Back #1 Bicycle Accident Settlements in California for 2024 and 2025
- Havas Reports the Progress of Transactions Under Its Current Share Buyback Program
- Yangarra Announces Operations Update
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
